The results suggest that differential proteins are enriched in Signal Transduction, Immune Disease, and Immune System pathways, indicating that Rh2-pre Exo treatment may affect intracellular processes such as immune system signaling and protein binding. The gene discussed is RHAG; the disease is glycogen storage disease VI.